01
Asset-Focused NewCoAsset-Focused NewCo
Establish independent NewCos around selected mRNA assets or specific application areas to drive dedicated funding and development.
Partnering with RNACure
Flexible Partnering Models
Flexible collaboration models to co-create the future of mRNA therapeutics
RNACure leverages its leading capabilities in mRNA design, LNP delivery, immune regulation, and CMC development to offer partners multi-layered, customizable collaboration pathways — advancing innovation from concept to clinical development and commercialization.
02
Product Licensing & Regional PartnershipProduct Licensing & Regional Partnership
Engage in product licensing, regional development, and commercialization collaborations for selected pipeline assets.
03
Platform-Based Co-DevelopmentPlatform-Based Co-Development
Leverage mRNA design, LNP delivery, CMC, and clinical translation capabilities to jointly develop innovative products.
04
LNP Delivery Collaboration & Lipid LicensingLNP Delivery Collaboration & Lipid Licensing
Provide customized LNP delivery solutions and core lipid molecule licensing collaborations.
05
CMC & Process Development SupportCMC & Process Development Support
Support IVT, purification, LNP formulation, analytical characterization, stability, and scale-up studies to advance projects toward the clinic.
06
Joint VentureJoint Venture
Establish joint ventures with strategic partners to integrate technology, capital, distribution channels, and operational resources for mutual growth.
Partnership Process
💬
Initial DiscussionInitial Discussion
📋
EvaluationEvaluation
👤
Collaboration DesignCollaboration Design
📁
Project ExecutionProject Execution
💻
Milestone ReviewMilestone Review
🤝
Long-term PartnershipLong-term Partnership
Contact Us
联系我们 / Contact Us
上海上海市杨浦区湾谷科技园C7座7-9楼
宝山上海市宝山区潘泾路2699号20幢
绍兴浙江省绍兴市越城区滨海新区海天道21号生命健康科技产业园5号楼北侧二、三楼-6层
广州广州市南沙区横沥镇明珠一街1号306房-A102开发大厦双创基地
